ADAR1 Capital Management, LLC 13D and 13G filings for Pieris Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-08-01 08:00 am Purchase | 2024-07-24 | 13G | Pieris Pharmaceuticals, Inc. PIRS | ADAR1 Capital Management, LLC | 138,641 10.500% | 138,641 (New Position) | Filing |